Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Polku Therapeutics Oy
OY
Active
Y-tunnus 3414544-3
Haartmaninkatu 4, 00290
Helsinki
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023
— employees
Watchlist
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Polku Therapeutics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
ST
Simon Thomas Bennett
Chief Executive Officer
Chief Executive Officer
2024
PS
Pasi Sebastian Soidinsalo
Confidential Clerk
Confidential Clerk
2024
Former (1)
TT
Timo Tapio Myöhänen
Deputy Member
Deputy Member
2024 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
RV
Rouslan Vladimirovich Michtchenko
Chairperson
2025
MM
Milla Maria Koistinaho
Board of Directors
2024
SJ
Sara Josepha Karoliina Kangaspeska
Board of Directors
2024
Former (1)
NS
Nikolay Savchuck
Chairperson
2024 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Polku Therapeutics Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network